Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab

@article{Szturz2015LongtermRO,
  title={Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab},
  author={Petr Szturz and Pol Specenier and Carl Laer and Danielle Den Weyngaert and Bob Corthouts and Laurens Carp and Eric Marck and Olivier Vanderveken and Jan B. Vermorken},
  journal={European Archives of Oto-Rhino-Laryngology},
  year={2015},
  volume={273},
  pages={1629-1636}
}
  • Petr Szturz, Pol Specenier, +6 authors Jan B. Vermorken
  • Published in European Archives of Oto-Rhino-Laryngology 2015
  • DOI:10.1007/s00405-015-3673-y
AbstractBackgroundIn recurrent head and neck squamous cell carcinoma ineligible for resection or irradiation, treatment aims primarily at symptom control and quality of life enhancement with an expected outcome of 6–12 months.MethodsIn 2005, a male patient, born in 1944, with a second local recurrence of human papillomavirus negative tonsil cancer was enrolled in the EXTREME trial, and randomized to platinum/5-fluorouracil/cetuximab arm resulting in partial remission with progression-free… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response

C Boeckx, C Weyn, I Vanden Bempt
  • BMC Res Notes
  • 2014

Feasibility of cetuximab plus sequential platinum-based therapy (TPF/CRT) in advanced squamous cell head and neck cancer (SCCHN): a randomized phase II study of the EORTC Head and Neck Cancer Group

JB Vermorken, E Remenar, D van den Weyngaert
  • Eur Arch Otorhinolaryngol 269:1311–1410 (abstract
  • 2012
VIEW 1 EXCERPT

Optimal treatment for recurrent/metastatic head and neck cancer.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2010
VIEW 3 EXCERPTS

Similar Papers

Loading similar papers…